SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-064424
Filing Date
2021-12-09
Accepted
2021-12-09 16:23:11
Documents
13
Period of Report
2021-12-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea152060-8k_bimiinter.htm   iXBRL 8-K 27091
2 FORM OF BOARD OF DIRECTORS AGREEMENT BETWEEN THE COMPANY AND INDEPENDENT DIRECTO ea152060ex10-1_bimiinter.htm EX-10.1 37328
  Complete submission text file 0001213900-21-064424.txt   249344

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE bimi-20211206.xsd EX-101.SCH 3022
4 XBRL LABEL FILE bimi-20211206_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE bimi-20211206_pre.xml EX-101.PRE 22357
6 EXTRACTED XBRL INSTANCE DOCUMENT ea152060-8k_bimiinter_htm.xml XML 3740
Mailing Address NO. 10, HUASHENG ROAD, FLOOR 21 YUZHONG DISTRICT CHONGQING, P.R. F4 404100
Business Address NO. 10, HUASHENG ROAD, FLOOR 21 YUZHONG DISTRICT CHONGQING, P.R. F4 404100 (8604) 1182209211
BIMI International Medical Inc. (Filer) CIK: 0001213660 (see all company filings)

IRS No.: 020563302 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34890 | Film No.: 211482259
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries